News

Simply Better Brands Corp. Announces Shares for Debt Transaction

VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. ("SBBC" or the "Company") (TSX Venture: SBBC,…

2 years ago

CloudMD Announces Resignation of Director

VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH)…

2 years ago

Emerging Markets Report: More Tools in the Toolbox

An Emerging Markets Sponsored Commentary ORLANDO, Fla., April 22, 2022 (GLOBE NEWSWIRE) -- Sometimes as we continue our coverage of…

2 years ago

CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant and Therapy Monitoring at Transplantation & Cellular Therapy Meetings

CareDx Announces that OTTR Patient Management Software Now Validated for SMART on FHIRSOUTH SAN FRANCISCO, Calif., April 22, 2022 (GLOBE…

2 years ago

PLx Pharma Inc. to Discuss 2022 First Quarter Financial Results on May 13, 2022 Conference Call and Provide Business Update

SPARTA, N.J., April 22, 2022 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug…

2 years ago

InvestmentPitch Media Video Discusses Reliq Health’s Signing of New Contracts in California, Texas and Nevada, with Two Physician Practices, a Hospital and a Skilled Nursing Facility

VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global…

2 years ago

Orion’s collaboration partner Bayer submits application for additional indication of darolutamide in China

ORION CORPORATION PRESS RELEASE 22 April 2022 at 11.30 EEST Orion’s collaboration partner Bayer submits application for additional indication of darolutamide…

2 years ago

Ultimovacs Receives Notice of Allowance on US Patent on Vaccine-Checkpoint Inhibitor Combinations

Extends protection for UV1 vaccine-checkpoint inhibitor combinations until at least 2037Covers UV1 with CTLA-4, PD-1 or PD-L1 checkpoint inhibitorsOslo, 22…

2 years ago

EssilorLuxottica’s first-quarter 2022 revenue: Another quarter of double-digit growth

EssilorLuxottica’s first-quarter 2022 revenue Another quarter of double-digit growth Revenue at Euro 5.6 billion, up 38% vs 2021Comparable2 revenue up…

2 years ago

Plantable Health Announces Partnership with Leading Sustainable Packaging Supplier, Grounded

New York, New York--(Newsfile Corp. - April 22, 2022) - Plantable® Health Inc. (NEO: PLBL) ("Plantable" or the "Company") today…

2 years ago